Regentis Biomaterials Ltd. Deferred Offering Costs
Regentis Biomaterials Ltd. (RGNT) had Deferred Offering Costs of $176.00 thousand as of 2025-12-05, per its 20-F/A filed 2026-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-02-27
- 2025-12-05: Deferred Offering Costs $176.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-12-05 | $176.00K 20-F/A · filed 2026-02-27 |